Milling, R. V., Grimm, D., Krüger, M., Grosse, J., Kopp, S., Bauer, J., . . . Wehland, M. (2018). Pazopanib, Cabozantinib, and Vandetanib in the Treatment of Progressive Medullary Thyroid Cancer with a Special Focus on the Adverse Effects on Hypertension. Int J Mol Sci.

Milling, Rikke Vilsbøll, Daniela Grimm, Marcus Krüger, Jirka Grosse, Sascha Kopp, Johann Bauer, Manfred Infanger, and Markus Wehland. "Pazopanib, Cabozantinib, and Vandetanib in the Treatment of Progressive Medullary Thyroid Cancer With a Special Focus On the Adverse Effects On Hypertension." Int J Mol Sci 2018.

Milling, Rikke Vilsbøll, et al. "Pazopanib, Cabozantinib, and Vandetanib in the Treatment of Progressive Medullary Thyroid Cancer With a Special Focus On the Adverse Effects On Hypertension." Int J Mol Sci 2018.